ArticleBioengineered2022

Oxymatrine induces anti-tumor response in cervical cancer by modulating circ_0008460/miR-197-3p/ribonucleotide reductase subunit M2 (RRM2).

Siwei Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.